BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22268619)

  • 1. Neutralization of Pseudomonas aeruginosa enzymatic activity by antibodies elicited with proteins of Larrea divaricata Cav.
    Sasso CV; Mattar de Anaya MA; Davicino RC; Martino R; Casali Y; Micalizzi B
    Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):346-53. PubMed ID: 22268619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross reaction between proteins from Larrea divaricata Cav. (jarilla) and cellular and extracellular proteins of Pseudomonas aeruginosa.
    Sasso C; de Anaya MA; Davicino R; Martino R; Casali Y; Correa S; Micalizzi B
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):695-701. PubMed ID: 22289085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reaction between proteins of Larrea divaricata Cav. (jarilla) and proteins of Gram-negative bacteria.
    de Anaya MA; Davicino R; Casali Y; Correa S; Micalizzi B
    Immunopharmacol Immunotoxicol; 2009; 31(4):654-60. PubMed ID: 19874237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with Larrea divaricata Cav. proteins elicits opsonic antibodies against Pseudomonas aeruginosa and induces phagocytic activity of murine macrophages.
    Canale FP; Dávila SDV; Sasso CV; Pellarín NW; Mattar Domínguez MA
    Microb Pathog; 2018 May; 118():257-267. PubMed ID: 29559255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mimicry between Larrea divaricata Cav. plant and a reference strain of Pseudomonas aeruginosa.
    Ferramola FF; Dávila SDV; Sasso CV; Mattar Domínguez MA
    Microb Pathog; 2020 Jan; 138():103818. PubMed ID: 31676366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of nordihydroguaiaretic acid in Larrea divaricata Cav. extracts by micellar electrokinetic chromatography.
    Stege PW; Sombra LL; Davicino RC; Olsina RA
    Phytochem Anal; 2011; 22(1):74-9. PubMed ID: 20848390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro immunomodulatory effects of fractions obtained from aqueous extracts of Larrea divaricata Cav (Jarilla) on mouse peritoneal macrophages.
    Martino RF; Davicino RC; Mattar MA; Casali YA; Correa SG; Anesini C; Micalizzi B
    Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):125-32. PubMed ID: 19831499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and apoptosis of mouse peritoneal macrophages by extracts of Larrea divaricata Cav. (jarilla).
    Davicino R; Mattar A; Casali Y; Porporatto C; Correa S; Micalizzi B
    Int Immunopharmacol; 2006 Dec; 6(13-14):2047-56. PubMed ID: 17161361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori.
    Stege PW; Davicino RC; Vega AE; Casali YA; Correa S; Micalizzi B
    Phytomedicine; 2006 Nov; 13(9-10):724-7. PubMed ID: 17085295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'In vivo' and 'in vitro' activity of Larrea divaricata Cav. on EL-4 cells.
    Davicino R; Alonso R; Anesini C
    Hum Exp Toxicol; 2011 Aug; 30(8):965-71. PubMed ID: 20864458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo immunomodulatory effects of aqueous extracts of Larrea divaricata Cav.
    Davicino R; Mattar A; Casali Y; Porporatto C; Correa SG; Micalizzi B
    Immunopharmacol Immunotoxicol; 2007; 29(3-4):351-66. PubMed ID: 18075849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages activation by a purified fraction, free of nordihydroguaiaretic acid (NDGA), from Larrea divaricata Cav. as a potential novel therapy against Candida albicans.
    Martino RF; Davicino RC; Mattar MA; Sasso CV; Casali YA; Alonso R; Anesini C; Correa SG; Micalizzi B
    Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):975-82. PubMed ID: 22551492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of an antiserum prepared against purified protease of pseudomonas aeruginosa (authors transl)].
    Sezen IY; Scharmann W; Blobel H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):126-32. PubMed ID: 808047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fungitoxic activity of Larrea divaricata cav. extracts.
    Quiroga EN; Sampietro AR; Vattuone MA
    Lett Appl Microbiol; 2004; 39(1):7-12. PubMed ID: 15189281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of an Aqueous Extract of Larrea divaricata Cav. during a Simulated Digestion Process.
    Alonso MR; Peralta I; Monti D; Martino R; Anesini C
    Phytother Res; 2017 Nov; 31(11):1708-1714. PubMed ID: 28857321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pseudomonas aeruginosa crude proteolytic fraction on antibacterial activity of Galleria mellonella haemolymph.
    Andrejko M
    Folia Biol (Krakow); 2004; 52(1-2):91-6. PubMed ID: 15521655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast.
    Goulet C; Khalf M; Sainsbury F; D'Aoust MA; Michaud D
    Plant Biotechnol J; 2012 Jan; 10(1):83-94. PubMed ID: 21895943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Cecropia pachystachya and Larrea divaricata aqueous extracts in mice.
    Bigliani MC; Grondona E; Zunino PM; Ponce AA
    Hum Exp Toxicol; 2010 Jul; 29(7):601-6. PubMed ID: 20051458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel extracellular protease from Pseudomonas aeruginosa MCM B-327: enzyme production and its partial characterization.
    Zambare V; Nilegaonkar S; Kanekar P
    N Biotechnol; 2011 Feb; 28(2):173-81. PubMed ID: 20951241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effect of three fractions of Larrea divaricata Cav. (jarilla) on the innate immune system: macrophage response against Candida albicans.
    Martino RF; Davicino RC; Mattar MA; Casali YA; Correa SG; Micalizzi B
    Mycoses; 2011 Nov; 54(6):e718-25. PubMed ID: 21615533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.